Chronic autoimmune urticaria in children

Allergologia et Immunopathologia

Volumn 37, Issue 1, 2009, Pages 43-47

  Cherrez Ojeda, I ^a   Cruz, E ^a   Leon R ^a   Mantilla, R ^a   Guerrero, T ^a   Soria, J ^a   Tafur, A ^b   Chica, L ^a   Gabino, G ^a  

^a Kennedy Hospital   (Ecuador)

^b MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHISTAMINIC AGENT; AUTOANTIBODY; COMPLEMENT; CYCLOSPORIN; DESLORATADINE; FEXOFENADINE; HISTAMINE; HYDROXYZINE; IMMUNOGLOBULIN; IMMUNOGLOBULIN G1; IMMUNOGLOBULIN G3; IMMUNOGLOBULIN G4; LEUKOTRIENE RECEPTOR BLOCKING AGENT; LEVOCETIRIZINE; LIPID; LORATADINE; MONTELUKAST; NONSTEROID ANTIINFLAMMATORY AGENT; OMALIZUMAB; PREDNISONE; THYROID ANTIBODY; THYROID HORMONE;

ALLERGY; ANGIONEUROTIC EDEMA; ANTIGEN BINDING; AUTOIMMUNE DISEASE; BEVERAGE; BLOOD PRESSURE MONITORING; CACAO; CHRONIC AUTOIMMUNE URTICARIA; CLINICAL FEATURE; DEVELOPING COUNTRY; DISEASE EXACERBATION; DISEASE PREDISPOSITION; DRUG APPROVAL; DRUG DOSE REDUCTION; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; DYSPNEA; FECES ANALYSIS; FOLLOW UP; HEADACHE; HISTAMINE RELEASE; HUMAN; IMMUNOMODULATION; KIDNEY FUNCTION; LIFESTYLE MODIFICATION; LIPID BLOOD LEVEL; MAST CELL; MORNING DOSAGE; NEUROLOGIC EXAMINATION; PATHOGENESIS; PATIENT MONITORING; PRICK TEST; PRURITUS; QUALITY OF LIFE; REVIEW; SKIN SWELLING; SKIN TEST; STRESS; SWIMMING; THORAX PAIN; THORAX RADIOGRAPHY; TREATMENT RESPONSE; URTICARIA;

ADOLESCENT; AUTOIMMUNE DISEASES; CHILD; CHRONIC DISEASE; HUMANS; SKIN TESTS; URTICARIA;

EID: 62549108183     PISSN: 03010546     EISSN: 15781267     Source Type: Journal    
DOI: 10.1016/S0301-0546(09)70251-4     Document Type: Review

References (50)

1. Hide M., Francis D.M., Grattan C.E., Hakimi J., Kochan J.P., and Greaves M.W. Autoantibodies against the high affinity IgE receptor as a cause of histamine release in chronic urticaria. N Engl J Med 328 (1993) 1599-1604
2. Greaves M.W. Chronic urticaria. N Engl J Med 332 (1995) 1767-1772
3. Powell R.J., Du Toitw G.L., and Siddiquez N. BSACI guidelines for the management of chronic urticaria and angio-oedema. Clinical and Experimental Allergy 37 (2007) 631-650
4. Grattan C.E.H., Francis D.M., Hide M., and Greaves M.W. Detection of circulating histamine releasing autoantibodies with functional properties of anti-IgE in chronic urticaria. Clin Exp Allergy 21 (1991) 695-704
5. Gruber B.L., Baeza M.L., Marchese M.J., Agnello V., and Kaplan A.P. Prevalence and functional role of anti-IgE autoantibodies in urticarial syndromes. J Invest Dermatol 90 (1988) 213
6. Sabroe R.A., Francis D.M., Barr R.M., and Greaves M.W. Anti-FceRI autoantibodies and basophil histamine releasability in chronic idiopathic urticaria. J Allergy Clin Immunol 102 (1998) 651-658
7. DeLong L., Culler S., Saini S., Beck L., and Chen S. Annual Direct and Indirect Health Care Costs of Chronic Idiopathic Urticaria A Cost Analysis of 50 Nonimmunosuppressed Patients. Arch Dermatol 144 1 (2008) 35-39
8. O'Donnell B.F., Lawlor F., Simpson J., Morgan M., and Greaves M.W. The impact of chronic urticaria on the quality of life. Br J Dermatol 136 (1997) 197-201
9. Brunetti L., Francavilla, and Miniello V. High prevalence of autoimmune urticaria in children with chronic urticaria. J Allergy Clin Immunol 114 (2004) 922-927
10. Grattan C.E.H., O'Donnell B.F., Francis D.M., et al. Randomized Doubleblind study of cyclosporin in chronic idiopathic urticaria. Br J Dermatol 143 (2000) 365-372
11. O'Donnell B.F., Barr R.M., Kobza Black A., et al. Intravenous immunoglobulin in autoimmune chronic urticaria. Br J Dermatol 138 (1998) 101-106
12. Zuberbier T., et al. EAACI/GALEN/EDF guideline: definition, classification and diagnosis of urticaria. Allergy 61 (2006) 316-320
13. Inamadar A.C., and Palit A. Management of autoimmune urticaria. Indian J Dermatol Venereol Leprol 74 (2008) 89-91
14. Sackesen Cansin, Sekerel B., and Orhan F. The Etiology of Different Forms of Urticaria in Childhood. Pediatric Dermatology 21 2 (2004) 102-108
15. Greaves M.W. Chronic idiopathic urticaria. Curr Opin Allergy Clin Immunol 3 (2003) 363-368
16. Kaplan A.P. Chronic urticaria: pathogenesis and treatment. J Allergy Clin Immunol 114 (2004) 465-474
17. Grob J.J., Revuz J., Ortonne J.P., et al. Comparative study of the of chronic urticaria, psoriasis and atopic dermatitis on the quality impact of life. Br J Dermatol 152 (2005) 289-295
18. Greaves M.W. Review article Series V: The skin as target for IgE-mediated allergic reactions. Allergy 55 (2000) 309-320
19. Kauppinen K., Juntunen K., and Lanki H. Urticaria in children retrospective evaluation and follow-up. Allergy 39 (1984) 469-472
20. Sackesen C., Sekerel B., and Orhan F. The etiology of different forms of Urticaria in Childhood. Pediatric Dermatology 21 2 (2004) 102-108
21. Sabroe R.A., Grattan C.E., and Francis D.M. The autologous serum skin test: a screening test for autoantibodies in chronic idiopathic urticaria. Br J Dermatol 140 (1999) 446-452
22. Sabroe R.A., Fiebiger E., Francis D.M.P.T., Grattan C.E., Black A.K., et al. Classification of anti-FcepsilonRI and anti-IgE autoantibodies in chronic idiopathic urticaria and correlation with disease severity. J Allergy Clin Immunol 110 (2002) 492-499
23. Niimi N., Francis D.M., Kermani F., et al. Dermal mast cell activation by autoantibodies against the high affinity IgE receptor in chronic urticaria. J Invest Dermatol 106 (1996) 1001-1006
24. Kermani F., Niimi N., Francis D.M., et al. Characterization of a novel mast cell-specific histamine releasing activity in chronic idiopathic urticaria (CIU). J Invest Dermatol 105 (1995) 452 (Abstract)
25. Claveau J., Lavoie A., Brunet C., et al. Chronic idiopathic urticaria: possible contribution of histamine-releasing factor to pathogenesis. J Allergy Clin Immunol 92 (1993) 132-137
26. Confino-Cohen R., Aharoni D., Goldberg A., et al. Evidence for aberrant regulation of the p21Ras pathway in PBMCs of patients with chronic idiopathic urticaria. J Allergy Clin Immunol 109 (2002) 349-356
27. Fiebiger E., Hammerschmid F., Stingl G., et al. Anti-FceRIa autoantibodies in autoimmune-mediated disorders. Identification of a structure-function relationship. J Clin Invest 101 (1998) 243-251
28. Soundararajan S., Kikuchi Y., Joseph K., and Kaplan A.P. Functional assessment of pathogenic IgG subclasses in chronic autoimmune urticaria. J Allergy Clin Immunol 115 (2005) 815-821
29. Kaplan A.P. Chronic urticaria: Pathogenesis treatment. J Allergy Clin Immunol 114 (2004) 465-474
30. Grattan C.E.H., and Francis D.M. Autoimmune urticaria. Adv Dermatol 15 (1999) 311-340
31. Grattan C.E.H., Francis D.M., Slater N.G.P., et al. Plasmapheresis for severe, unremitting, chronic urticaria. Lancet 339 (1992) 1078-1080
32. Sabroe R., Seed P., Francis D., Barr R., Kobza A., and Greaves M. Chronic idiopathic urticaria: Comparison of the clinical features of patients with ondurthout anti FCER1 or anti IgE auto antibodies. J Am Acad Dermatol 40 (1999) 443-450
33. Mamatha G., Balachandran C., and Prabhu S. Chronic idiopathic urticaria: Comparison of clinical features with positive autologous serum skin test. Indian J Dermatol Venereol Leprol 74 (2008) 105-108
34. Cherrez-Ojeda I., Tafur A., Cazar T., Uraga E., Mantilla R., Guerrero T., et al. Diagnosis of chronic urticaria in Guayaquil. Archivos de Alergia e Inmunologia Clinica 38 1 (2007)
35. Sabroe R.A., Grattan C.E.H., Francis D.M., et al. The autologous serum skin test: a screening test for autoantibodies in chronic idiopathic urticaria. Br J Dermatol 140 (1999) 446-472
36. Grattan C.E.H., Boon A.P., Eady R.A.J., et al. The pathology of the autologous serum skin test response in chronic urticaria resembles IgE-mediated late-phase reactions. Int Arch Allergy Appl Immunol 93 (1990) 198-204
37. Fusari A., Colangelo C., Bonifazi F., et al. The autologous serum skin test in the follow-up of patients with chronic urticaria. Allergy 60 (2005) 256-258
38. Hizal M., Tuzun B., Wolf R., et al. The relationship between Helicobacter pylori IgG antibody and autologous serum test in chronic urticaria. Int J Dermatol 39 (2000) 443-445
39. Baskan E.B., Turker T., and Gulten M. Lack of correlation between Helicobacter pylori infection and autologous serum skin test in chronic idiopathic urticaria. International Journal of Dermatology 44 12 (2005) 993-995
40. Kimura R., Morii S., Kato K., et al. Autoimmune urticaria at 3 years of age diagnosed by puncuture skin test using. Allergy 62 (2007) 1218-1219
41. Kikuchi Y., and Kaplan A.P. Mechanisms of autoimmune activation of basophils in chronic urticaria. J Allergy Clin Immunol 107 (2001) 1056-1062
42. Hoskin S.L., Wilson S.J., Sabroe R.A., et al. Basophil infiltration of weals in chronic idiopathic urticaria. J Allergy Clin Immunol 109 (2002) A229
43. Grattan C.E.H., Dawn G., Gibbs S., et al. Blood basophil numbers in chronic ordinary urticaria and healthy controls: diurnal variation, influence of loratadine and prednisolone and relationship to disease activity. Clin Exp Allergy 33 (2003) 337-341
44. Gyimesi E., Sipka S., Danko K., et al. Basophil CD63 expression assay on highly sensitized atopic donor leucocytes - a useful method in chronic autoimmune urticaria. Br J Dermatol 151 (2004) 388-396
45. Simons F. Safety of levocetirizine treatment in young atopic children: an 18-month study. Pediatr Allergy Immunol 18 (2007) 535-542
46. Hampel F. Kittner Safety and tolerability of fexofenadine hydrochloride, 15 and 30 mg, twice daily in children aged 6 months to 2 years with allergic rhinitis. Ann Allergy Asthma Immunol 99 6 (2007 Dec) 549-554
47. Bloom M., Staudinger H., and Herron J. Safety of desloratadine syrup in children. Curr Med Res Opin 20 (2004) 1959-1965
48. Erbagci Z. The leukotriene receptor antagonist montelukast in the treatment of chronic idiopathic urticaria: a single-blind, placebocontrolled, crossover clinical study. J Allergy Clin Immunol 110 (2002) 484-488
49. Godse K. Oral montelukast monotherapy is ineffective in chronic idiopathic urticaria: a comparison with oral cetirizine. Indian J Dermatol Venereol Leprol 72 (2006) 312-314
50. Kaplan A., Kusumam J., Maykut R., Geba G., and Zeldin R. Treatment of chronic autoimmune urticaria with Omalizumab. J Allergy Clin Immunol 122 (2008) 569-573